The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles. (November 2018)
- Record Type:
- Journal Article
- Title:
- The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles. (November 2018)
- Main Title:
- The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles
- Authors:
- Wang, Ji-Long
Du, Xiao-Jiao
Yang, Jin-Xian
Shen, Song
Li, Hong-Jun
Luo, Ying-Li
Iqbal, Shoaib
Xu, Cong-Fei
Ye, Xiao-Dong
Cao, Jie
Wang, Jun - Abstract:
- Abstract: Engineering nanoparticles of reasonable surface poly(ethylene glycol) (PEG) length is important for designing efficient drug delivery systems. Eliminating the disturbance by other nanoproperties, such as size, PEG density, etc., is crucial for systemically investigating the impact of surface PEG length on the biological behavior of nanoparticles. In the present study, nanoparticles with different surface PEG length but similar other nanoproperties were prepared by using poly(ethylene glycol)-block-poly(ε-caprolactone) (PEG- b -PCL) copolymers of different molecular weights and incorporating different contents of PCL3500 homopolymer. The molecular weight of PEG block in PEG-PCL was between 3400 and 8000 Da, the sizes of nanoparticles were around 100 nm, the terminal PEG density was controlled at 0.4 PEG/nm 2 (or the frontal PEG density was controlled at 0.16 PEG/nm 2 ). Using these nanoproperties well-designed nanoparticles, we demonstrated PEG length-dependent changes in the biological behaviors of nanoparticles and exhibited nonmonotonic improvements as the PEG molecular weight increased from 3400 to 8000 Da. Moreover, under the experimental conditions, we found nanoparticles with a surface PEG length of 13.8 nm (MW = 5000 Da) significantly decreased the absorption with serum protein and interaction with macrophages, which led to prolonged blood circulation time, enhanced tumor accumulation and improved antitumor efficacy. The present study will help to establishAbstract: Engineering nanoparticles of reasonable surface poly(ethylene glycol) (PEG) length is important for designing efficient drug delivery systems. Eliminating the disturbance by other nanoproperties, such as size, PEG density, etc., is crucial for systemically investigating the impact of surface PEG length on the biological behavior of nanoparticles. In the present study, nanoparticles with different surface PEG length but similar other nanoproperties were prepared by using poly(ethylene glycol)-block-poly(ε-caprolactone) (PEG- b -PCL) copolymers of different molecular weights and incorporating different contents of PCL3500 homopolymer. The molecular weight of PEG block in PEG-PCL was between 3400 and 8000 Da, the sizes of nanoparticles were around 100 nm, the terminal PEG density was controlled at 0.4 PEG/nm 2 (or the frontal PEG density was controlled at 0.16 PEG/nm 2 ). Using these nanoproperties well-designed nanoparticles, we demonstrated PEG length-dependent changes in the biological behaviors of nanoparticles and exhibited nonmonotonic improvements as the PEG molecular weight increased from 3400 to 8000 Da. Moreover, under the experimental conditions, we found nanoparticles with a surface PEG length of 13.8 nm (MW = 5000 Da) significantly decreased the absorption with serum protein and interaction with macrophages, which led to prolonged blood circulation time, enhanced tumor accumulation and improved antitumor efficacy. The present study will help to establish a relatively precise relationship between surface PEG length and the in vivo behavior of nanoparticles. … (more)
- Is Part Of:
- Biomaterials. Volume 182(2018)
- Journal:
- Biomaterials
- Issue:
- Volume 182(2018)
- Issue Display:
- Volume 182, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 182
- Issue:
- 2018
- Issue Sort Value:
- 2018-0182-2018-0000
- Page Start:
- 104
- Page End:
- 113
- Publication Date:
- 2018-11
- Subjects:
- Polymeric nanoparticles -- PEG length -- PEG density -- Drug delivery -- Cancer therapy
Biomedical materials -- Periodicals
Biocompatible Materials -- Periodicals
Biomatériaux -- Périodiques
610.28 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01429612 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01429612 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01429612 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.biomaterials.2018.08.022 ↗
- Languages:
- English
- ISSNs:
- 0142-9612
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.715000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18011.xml